Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE:DNA
Total Valuation
Ginkgo Bioworks Holdings has a market cap or net worth of $419.08M. The enterprise value is $672.82M.
Market Cap$419.08M
Enterprise Value$672.82M
Share Statistics
Ginkgo Bioworks Holdings has 49,941,880 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,941,880
Owned by Insiders1.00%
Owned by Institutions14.46%
Financial Efficiency
Ginkgo Bioworks Holdings’s return on equity (ROE) is -0.61 and return on invested capital (ROIC) is -30.71%.
Return on Equity (ROE)-0.61
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-30.71%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee204.02K
Profits Per Employee-375.02K
Employee Count834
Asset Turnover0.15
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ginkgo Bioworks Holdings is ―. Ginkgo Bioworks Holdings’s PEG ratio is 0.03.
PE Ratio―
PS Ratio2.71
PB Ratio0.91
Price to Fair Value0.91
Price to FCF-2.58
Price to Operating Cash Flow-2.21
PEG Ratio0.03
Income Statement
In the last 12 months, Ginkgo Bioworks Holdings had revenue of 170.16M and earned -312.76M in profits. Earnings per share was -5.64.
Revenue170.16M
Gross Profit138.63M
Operating Income-315.28M
Pretax Income-313.60M
Net Income-312.76M
EBITDA-254.61M
Earnings Per Share (EPS)-5.64
Cash Flow
In the last 12 months, operating cash flow was -171.06M and capital expenditures -22.98M, giving a free cash flow of -194.04M billion.
Operating Cash Flow-171.06M
Free Cash Flow-194.04M
Free Cash Flow per Share-3.89
Dividends & Yields
Ginkgo Bioworks Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.88
52-Week Price Change2.71%
50-Day Moving Average8.79
200-Day Moving Average10.39
Relative Strength Index (RSI)39.58
Average Volume (3m)1.18M
Important Dates
Ginkgo Bioworks Holdings upcoming earnings date is May 13, 2026, After Close (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
Ginkgo Bioworks Holdings as a current ratio of 4.92, with Debt / Equity ratio of 82.01%
Current Ratio4.92
Quick Ratio4.92
Debt to Market Cap0.91
Net Debt to EBITDA-0.98
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Ginkgo Bioworks Holdings has paid -837.00K in taxes.
Income Tax-837.00K
Effective Tax Rate<0.01
Enterprise Valuation
Ginkgo Bioworks Holdings EV to EBITDA ratio is -2.79, with an EV/FCF ratio of -3.98.
EV to Sales4.18
EV to EBITDA-2.79
EV to Free Cash Flow-3.98
EV to Operating Cash Flow-4.15
Balance Sheet
Ginkgo Bioworks Holdings has $422.62M in cash and marketable securities with $417.08M in debt, giving a net cash position of $5.54M billion.
Cash & Marketable Securities$422.62M
Total Debt$417.08M
Net Cash$5.54M
Net Cash Per Share$0.11
Tangible Book Value Per Share$8.14
Margins
Gross margin is 81.48%, with operating margin of -185.29%, and net profit margin of -183.81%.
Gross Margin81.48%
Operating Margin-185.29%
Pretax Margin-184.30%
Net Profit Margin-183.81%
EBITDA Margin-149.63%
EBIT Margin-184.30%
Analyst Forecast
The average price target for Ginkgo Bioworks Holdings is $8.50, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$8.50
Price Target Upside-4.06% Downside
Analyst ConsensusModerate Sell
Analyst Count3
Revenue Growth Forecast-17.13%
EPS Growth Forecast51.74%